Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine β‑synthase, H2S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy The […]
The French National Drug Agency or ANSM (Agence Nationale de Sécurité du Médicament) authorizes a clinical trial for Leucettinib-21, a drug to correct cognitive deficits associated […]
On October 17th, the scientific board of the Fondation Jérôme Lejeune met in Paris to select the best research projects among those submitted in this call for […]
An international jury attributed this spring season 5 postdoctoral grants to young researchers working on Down syndrome (DS) and other associated pathologies The research projects of […]
The recipients of the Jerome Lejeune Young Researcher Award 2022 are two young scientists that are completing or have completed their PhD thesis on intellectual disabilities of […]
This year, the beneficiaries of the Jérôme Lejeune 4th-year PhD Scholarships are two young scientists who are completing their PhD thesis on intellectual disabilities of genetic […]
Within the framework of the Jérôme Lejeune Foundation Grants programme, we are pleased to announce the projects selected in the Autumn 2022 call for grants, which […]
6-7 October 2022. Paris, France Last October, the Jérôme Lejeune Foundation had the pleasure to co-organise and host in our headquarters in Paris, the 1st International […]
9-12 June 2022. Long Beach, California. USA The Trisomy 21 Research Society (T21RS) is the first international non-profit scientific organisation of researchers working on Trisomy 21. […]